Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › CONCORD › EMERSON HOSPITAL

EMERSON HOSPITAL

NPI: 1922103357 · CONCORD, MA 01742 · Physical Therapy Clinic/Center · NPI assigned 09/13/2006

$18.61M
Total Medicaid Paid
688,767
Total Claims
574,551
Beneficiaries
267
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWILHELM, JACK (SR VP FINANCE &ADMIN)
NPI Enumeration Date09/13/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 73,590 $1.92M
2019 82,378 $2.21M
2020 80,085 $2.07M
2021 111,348 $3.03M
2022 120,138 $3.36M
2023 120,156 $2.89M
2024 101,072 $3.13M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
96361 Intravenous infusion, hydration; each additional hour 6,053 5,091 $1.94M
99284 Emergency department visit for the evaluation and management, high severity 12,705 11,611 $1.82M
99283 Emergency department visit for the evaluation and management, moderate severity 10,808 10,046 $1.54M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 9,911 8,897 $1.46M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 24,536 8,115 $1.40M
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 19,273 15,446 $1.15M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4,038 2,686 $511K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,810 3,152 $468K
59025 Fetal non-stress test 1,525 682 $398K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 9,532 3,814 $396K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 4,096 1,447 $338K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,898 2,758 $321K
97530 Therapeutic activities, direct patient contact, each 15 minutes 6,573 2,664 $286K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2,842 2,650 $279K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 8,841 7,325 $279K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 9,879 3,671 $271K
70450 Computed tomography, head or brain; without contrast material 2,569 2,399 $268K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,874 1,678 $204K
77063 Screening digital breast tomosynthesis, bilateral 2,927 2,890 $199K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,008 5,205 $185K
S9485 Crisis intervention mental health services, per diem 307 261 $164K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 38,623 32,636 $157K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1,070 564 $157K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,105 1,004 $154K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 8,798 8,562 $151K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 219 214 $148K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5,718 5,539 $148K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 8,450 7,204 $147K
97161 2,464 2,334 $146K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 5,693 5,514 $145K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,239 931 $133K
84443 Thyroid stimulating hormone (TSH) 13,660 13,112 $123K
97803 1,462 1,376 $111K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 3,528 3,185 $111K
90791 Psychiatric diagnostic evaluation 2,689 2,433 $108K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2,640 2,517 $103K
71046 Radiologic examination, chest; 2 views 6,649 6,212 $100K
80053 Comprehensive metabolic panel 32,304 28,204 $91K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 581 561 $89K
83970 3,638 3,522 $82K
ATP14 12,218 9,576 $82K
77067 Screening mammography, bilateral, including computer-aided detection 3,324 3,278 $80K
G0378 Hospital observation service, per hour 886 724 $78K
76705 Ultrasound, abdominal, real time with image documentation; limited 950 902 $77K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2,895 2,844 $68K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3,139 2,181 $65K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 582 352 $56K
87086 Culture, bacterial; quantitative colony count, urine 11,053 10,151 $53K
82728 6,364 6,155 $52K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,005 948 $51K
99215 Prolong outpt/office vis 315 302 $50K
83036 Hemoglobin; glycosylated (A1C) 9,949 9,644 $49K
82607 5,731 5,577 $47K
88305 Level IV - Surgical pathology, gross and microscopic examination 3,174 3,023 $46K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2,611 2,553 $46K
76642 569 485 $45K
99205 Prolong outpt/office vis 233 226 $37K
84484 6,158 5,172 $36K
84425 2,721 2,646 $36K
85027 9,104 8,481 $35K
74176 Computed tomography, abdomen and pelvis; without contrast material 389 359 $33K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 7,739 6,136 $32K
99282 Emergency department visit for the evaluation and management, low to moderate severity 254 248 $31K
82746 3,589 3,487 $31K
87081 5,841 5,645 $30K
84703 5,800 5,328 $30K
86780 2,983 2,921 $30K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 11,720 10,560 $28K
ATP17 3,973 3,474 $27K
84439 5,113 4,903 $27K
83550 5,015 4,859 $26K
86850 3,950 3,681 $25K
83540 6,280 6,075 $24K
86803 2,430 2,376 $24K
87077 4,488 4,212 $24K
83735 6,939 5,776 $23K
83013 504 494 $23K
84134 2,474 2,321 $22K
80048 Basic metabolic panel (calcium, ionized) 11,717 9,902 $22K
J3490 Unclassified drugs 1,173 866 $22K
83880 1,793 1,619 $21K
87480 1,468 1,394 $21K
87660 1,468 1,394 $21K
87510 1,466 1,393 $21K
83690 4,936 4,434 $20K
ATP08 4,373 3,384 $17K
84590 2,311 2,263 $17K
ATP15 2,661 2,106 $17K
80050 General health panel 1,256 1,239 $16K
85610 8,742 6,404 $16K
80061 Lipid panel 9,995 9,755 $15K
81003 13,339 12,123 $15K
86140 5,060 4,622 $15K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 139 130 $15K
87186 3,059 2,876 $14K
86618 1,376 763 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,745 1,845 $14K
85730 3,785 3,580 $13K
73630 518 477 $12K
88342 740 706 $12K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 380 310 $12K
84702 1,017 777 $12K
97162 263 242 $11K
86900 3,902 3,641 $10K
84446 1,066 1,036 $10K
96375 Therapeutic injection; each additional sequential IV push 6,055 4,409 $9K
87070 1,921 1,779 $9K
87340 1,137 1,112 $9K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 52 51 $9K
82784 1,059 1,023 $8K
86901 3,882 3,621 $8K
76770 66 62 $8K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 296 271 $7K
84597 821 802 $7K
74246 43 42 $7K
85651 3,389 3,162 $7K
97802 93 93 $7K
82948 2,847 1,978 $7K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 57 55 $6K
86762 517 506 $6K
73610 181 174 $6K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,945 2,612 $6K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 37 37 $5K
J3010 Injection, fentanyl citrate, 0.1 mg 3,915 3,271 $5K
97535 Self-care/home management training, each 15 minutes 144 98 $5K
76536 65 64 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg 6,395 4,859 $5K
87040 1,238 682 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg 3,478 2,833 $5K
81001 2,713 2,448 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 454 429 $5K
83605 966 806 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 13 12 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg 2,651 2,386 $4K
82043 1,889 1,833 $4K
73564 183 176 $4K
83516 524 334 $4K
93976 56 54 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 39 38 $4K
80076 3,414 3,153 $4K
97116 253 126 $4K
93971 61 54 $4K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 431 217 $4K
93017 77 76 $4K
84153 392 371 $4K
87205 1,663 1,555 $4K
84466 523 502 $4K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 122 120 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 16 14 $4K
J7050 Infusion, normal saline solution, 250 cc 3,001 1,803 $3K
85379 542 503 $3K
76830 Ultrasound, transvaginal 41 37 $3K
74018 115 107 $3K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 2,788 2,739 $3K
87147 762 715 $3K
83014 504 494 $3K
J2704 Injection, propofol, 10 mg 1,392 1,219 $3K
83655 237 234 $3K
87653 89 88 $3K
36415 Collection of venous blood by venipuncture 26,863 20,705 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 76 71 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 778 681 $2K
87088 492 467 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,609 1,449 $2K
ATP03 544 473 $2K
77066 Tomosynthesis, mammo 39 39 $2K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 30 13 $2K
83721 322 316 $2K
84146 134 131 $2K
70551 Magnetic resonance imaging, brain; without contrast material 12 12 $2K
87807 158 151 $2K
84403 84 83 $2K
86480 27 27 $2K
74247 12 12 $1K
71260 Computed tomography, thorax, diagnostic; with contrast material 24 24 $1K
74240 13 12 $1K
86038 183 175 $1K
82950 276 274 $1K
84255 74 73 $1K
82378 75 65 $986.10
J0690 Injection, cefazolin sodium, 500 mg 717 619 $963.43
73030 43 37 $955.53
J1170 Injection, hydromorphone, up to 4 mg 1,022 597 $837.59
84480 130 126 $767.93
84630 106 105 $703.36
77080 14 14 $656.30
84100 1,977 1,720 $653.61
81002 680 645 $643.17
94761 14,647 12,937 $602.31
84402 30 29 $546.06
82525 77 76 $523.16
88142 25 25 $522.25
71275 Computed tomographic angiography, chest, with contrast material 12 12 $480.02
93041 2,991 2,796 $432.74
ATP07 93 88 $430.77
72100 25 25 $367.75
87899 59 52 $358.03
90792 Psychiatric diagnostic evaluation with medical services 32 30 $340.85
51798 96 89 $329.30
71250 25 25 $325.07
71045 Radiologic examination, chest; single view 283 261 $315.10
88304 14 13 $315.00
ATP02 79 65 $306.23
72125 Computed tomography, cervical spine; without contrast material 111 105 $298.77
84460 511 491 $296.59
87427 85 41 $291.68
85048 1,008 860 $289.07
82565 504 475 $282.76
84450 247 238 $263.62
80320 780 472 $258.55
86255 13 13 $230.79
86430 68 65 $224.40
ATP18 47 38 $197.91
87046 43 41 $196.81
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 12 12 $193.36
ATP11 35 32 $182.20
84550 384 346 $176.39
0002A 26 26 $170.34
80164 56 51 $152.43
Q3014 Telehealth originating site facility fee 446 320 $144.16
87015 44 42 $139.07
82570 31 24 $133.04
87328 15 15 $131.28
87329 15 15 $131.28
82550 165 149 $124.47
86258 12 12 $122.04
81514 241 225 $118.35
87207 29 27 $114.87
83020 15 12 $113.50
G0103 Prostate cancer screening; prostate specific antigen test (psa) 246 241 $113.19
73130 12 12 $107.34
86706 14 13 $98.00
J2270 Injection, morphine sulfate, up to 10 mg 903 624 $74.32
83615 592 488 $61.96
83001 13 13 $49.17
36416 4,598 2,949 $36.74
ATP10 13 13 $35.84
85045 15 13 $32.96
82040 112 107 $31.57
82247 36 24 $22.15
80178 13 12 $20.46
86364 14 14 $10.17
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,129 3,822 $7.50
82248 112 87 $4.43
82947 19 17 $3.58
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 57 53 $0.33
96376 1,208 787 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 514 474 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 122 59 $0.00
J2060 Injection, lorazepam, 2 mg 383 256 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 505 471 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 31 25 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 13 13 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 16 12 $0.00
A9585 Injection, gadobutrol, 0.1 ml 39 39 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 111 105 $0.00
84145 345 300 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 1,002 909 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 356 242 $0.00
80323 286 205 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 138 125 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 280 265 $0.00
84520 39 36 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 145 141 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 66 63 $0.00
99238 Hospital discharge day management, 30 minutes or less 15 15 $0.00
J1171 Injection, hydromorphone, 0.1 mg 21 14 $0.00